CI vs RMD: fair value comparison
The Cigna Group and ResMed Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, RMD currently sits closer to the top of our discount ranking. RMD carries the stronger quality grade. RMD carries the stronger momentum grade.
| CI | RMD | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $278.88 | $240.33 |
| 12-month range | $244.41–$299.21 | $186.44–$270.99 |
| Sector rank | #32 of 113 Healthcare | #27 of 113 Healthcare |
| Quality grade | F | A |
| Momentum grade | D | A |
| Leverage | Moderate | Low |
| Margin trend | Contracting | Expanding |
| Revenue growth | Strong | Strong |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Fairly Valued | Overvalued |
| 52-week position | The upper-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: CI fair value analysis · RMD fair value analysis